![Manisha Pai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manisha Pai
Corporate Officer/Principal chez
VERTEX PHARMACEUTICALS INCORPORATED
Profil
Manisha Pai is currently Executive Director-Investor Relations at Vertex Pharmaceuticals, Inc. since 2020.
Former roles include Head-Public Relations at Millennium Pharmaceuticals, Inc. from 2008 to 2013, Head-Public Relations at Pharmacyclics LLC from 2013 to 2014, Head-IR & Corporate Communications at Epizyme, Inc. from 2014 to 2015, Head-IR & Corporate Communications at Genetix Biotherapeutics, Inc. from 2015 to 2017, and Vice President-Investor Relations & Communications at Magenta Therapeutics, Inc. Education includes undergraduate studies at Amherst College.
Postes actifs de Manisha Pai
| Sociétés | Poste | Début |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/09/2020 |
Anciens postes connus de Manisha Pai
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Investor Relations Contact | 01/10/2017 |
| EPIZYME, INC. | Investor Relations Contact | 01/04/2015 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/01/2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/07/2013 |
| MAGENTA THERAPEUTICS | Investor Relations Contact | - |
Formation de Manisha Pai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
